Nanomedicine News RSS Feed - Nanomedicine

Liposomes with Embedded Nanoparticles May Help Treat Cancer

Liposomes with Embedded Nanoparticles May Help Treat Cancer

In the race to find more effective ways to treat cancer, Boise State University biophysicist Daniel Fologea is working outside the rules of general mathematics that say one plus one equals two. In his world, one plus one adds up to a whole lot more. [More]
Targeted Nanoparticle May Help Regenerate Healthy Heart Tissue without Using Stem Cells

Targeted Nanoparticle May Help Regenerate Healthy Heart Tissue without Using Stem Cells

A targeted nanoparticle created by researchers at North Carolina State University and the Cedars-Sinai Heart Institute may help heart attack patients regenerate healthy heart tissue without using donated or processed stem cells. This new nanomedicine could also alleviate some of the difficulties involved with stem cell therapy, including treatment delays and invasive procedures. [More]
Nanorobotic Techniques and AFM Help Study Pathology of Autoimmune Skin Disease

Nanorobotic Techniques and AFM Help Study Pathology of Autoimmune Skin Disease

University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin. This information provides new insights into autoimmune mechanisms in general and could help develop and screen treatments for patients suffering from all autoimmune diseases, estimated to affect 5-10 percent of the U.S. population. [More]
Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Antibody-Studded Iron Nanoparticles Help Treat Heart Attack Damage

Researchers at the Cedars-Sinai Heart Institute infused antibody-studded iron nanoparticles into the bloodstream to treat heart attack damage. The combined nanoparticle enabled precise localization of the body's own stem cells to the injured heart muscle. [More]
Senesco Technologies Changes Name to Sevion Therapeutics

Senesco Technologies Changes Name to Sevion Therapeutics

Senesco Technologies, Inc., a clinical-stage company which discovers, develops and acquires next-generation biologics for the treatment of cancer and immunological diseases, announced today a corporate rebranding under which the Company will change its name to Sevion Therapeutics, Inc. [More]
NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

NanoViricides Reports Further Progress in Development of Anti-Ebola Drug Program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reported further progress in its anti-Ebola drug development program. The Company has designed novel anti-Ebola broad-spectrum drug candidates that are expected to continue to work in spite of mutations, and has commenced synthesis of the same. [More]
Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Inventor of Miniaturized Technologies to Improve Human Health Wins $500,000 Lemelson-MIT Prize

Dr. Sangeeta Bhatia, biomedical engineer and professor at MIT, is the recipient of the 2014 $500,000 Lemelson-MIT Prize. Bhatia is recognized for designing and commercializing miniaturized technologies with applications to improve human health. [More]
Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced pre-clinical data presented on Sunday, September 7, 2014, at 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC. [More]
PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

PharmAthene, Nanotherapeutics Enter Alliance to Advance Medical Countermeasures for Biodefense

PharmAthene, Inc. and Nanotherapeutics, Inc., a privately-held biopharmaceutical company, announced today that they have formed a Strategic Alliance to advance the development of certain medical countermeasures for the U.S. biodefense market. [More]
SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

SUNY CNSE/SUNYIT Awarded Grant to Identify Cancer Cell Signals using Nanotechnology-Enabled Methods

The newly merged SUNY College of Nanoscale Science and Engineering (CNSE)/SUNY Institute of Technology (SUNYIT) institution today announced the National Institute of Environmental Health Sciences has awarded a $1.65 million grant to further research conducted by nanobioscience professor Dr. Thomas Begley that identifies signals which cancer cells use to respond to their environment. [More]